标记具有大量资产负债表灵活性的中小市值工具公司

USA | Life Science Tools & Diagnostics  * Jefferies LLC / Jefferies Research Services, LLC Matthew Stanton *  | Equity Analyst(615) 963-8397 | mstanton@jefferies.comTycho Peterson *  | Equity Analyst+1 (212) 738-5583 | tpeterson2@jefferies.comJack Melick, CPA *  | Equity Associate+1 (617) 345-8671 | jmelick@jefferies.comPriya Patel *  | Equity Associate+1 (332) 204-0140 | ppatel5@jefferies.comNoah Kava *  | Equity Associate+1 (212) 323-3939 | nkava@jefferies.comLauren Timmins, Ph.D. *  | Equity Associate+1 (929) 237-2038 (mobile) | ltimmins@jefferies.comFlagging Pair of SMID Tools Names with Plentyof Balance Sheet OptionalityWe flag a pair of SMID cap tools names with plenty of balance sheet optionality.AZTA: ~$550M cash, preference for organic investments (growth, margininitiatives) and tuck-in M&A but don't rule out buyback with I-day in 2H25 alsopotential catalyst. CYRX: following pending PDP deal close (soon) will have ~$250M net cash with potential for share repo ($74M authorizati